Eiry Roberts is Chief Medical Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 23,716 shares of NBIX, which is worth approximately $2.85 Million. The most recent transaction as insider was on Feb 13, 2024, when has been sold 1,114 shares (Common Stock) at a price of $132.96 per share, resulting in proceeds of $148,117. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.7K
0% 3M change
19.66% 12M change
Total Value Held $2.85 Million

EIRY ROBERTS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2024
SELL
Open market or private sale
$148,117 $132.96 p/Share
1,114 Reduced 4.49%
23,716 Common Stock
Feb 08 2024
SELL
Open market or private sale
$131,525 $134.21 p/Share
980 Reduced 4.14%
22,717 Common Stock
Feb 06 2024
SELL
Open market or private sale
$159,451 $142.24 p/Share
1,121 Reduced 4.88%
21,837 Common Stock
Jan 31 2024
SELL
Open market or private sale
$205,131 $140.79 p/Share
1,457 Reduced 6.54%
20,832 Common Stock
Dec 22 2023
SELL
Open market or private sale
$1,267,400 $126.74 p/Share
10,000 Reduced 33.87%
19,521 Common Stock
Dec 12 2023
SELL
Open market or private sale
$1,675,316 $120.31 p/Share
13,925 Reduced 32.05%
29,521 Common Stock
Dec 12 2023
BUY
Exercise of conversion of derivative security
$1,128,621 $81.05 p/Share
13,925 Added 27.63%
36,468 Common Stock
Dec 08 2023
SELL
Open market or private sale
$36,024 $120.08 p/Share
300 Reduced 1.01%
29,521 Common Stock
Dec 08 2023
BUY
Exercise of conversion of derivative security
$24,315 $81.05 p/Share
300 Added 1.0%
29,621 Common Stock
Dec 07 2023
SELL
Open market or private sale
$9,314,110 $120.37 p/Share
77,379 Reduced 72.38%
29,521 Common Stock
Dec 07 2023
BUY
Exercise of conversion of derivative security
$6,106,750 $78.92 p/Share
77,379 Added 65.2%
41,296 Common Stock
Dec 06 2023
SELL
Open market or private sale
$1,007,771 $120.03 p/Share
8,396 Reduced 22.14%
29,521 Common Stock
Dec 06 2023
BUY
Exercise of conversion of derivative security
$653,292 $77.81 p/Share
8,396 Added 18.13%
37,917 Common Stock
Aug 21 2023
SELL
Open market or private sale
$343,401 $107.38 p/Share
3,198 Reduced 9.77%
29,521 Common Stock
Apr 24 2023
SELL
Open market or private sale
$1,490,112 $103.48 p/Share
14,400 Reduced 35.08%
26,644 Common Stock
Feb 08 2023
SELL
Open market or private sale
$102,076 $104.16 p/Share
980 Reduced 2.33%
41,015 Common Stock
Feb 07 2023
SELL
Open market or private sale
$1,476,729 $102.38 p/Share
14,424 Reduced 26.44%
40,135 Common Stock
Feb 06 2023
SELL
Open market or private sale
$118,601 $105.8 p/Share
1,121 Reduced 3.96%
27,176 Common Stock
Jan 31 2023
SELL
Open market or private sale
$160,255 $109.99 p/Share
1,457 Reduced 5.27%
26,171 Common Stock
Feb 08 2022
SELL
Open market or private sale
$77,930 $79.52 p/Share
980 Reduced 3.83%
24,625 Common Stock
Feb 07 2022
SELL
Open market or private sale
$221,688 $80.79 p/Share
2,744 Reduced 10.36%
23,746 Common Stock
Jan 10 2022
SELL
Open market or private sale
$196,084 $74.5 p/Share
2,632 Reduced 11.01%
21,279 Common Stock
Feb 08 2021
SELL
Open market or private sale
$275,880 $116.75 p/Share
2,363 Reduced 11.22%
18,693 Common Stock
Jan 08 2021
SELL
Open market or private sale
$292,310 $111.06 p/Share
2,632 Reduced 14.24%
15,845 Common Stock
Nov 12 2020
SELL
Open market or private sale
$204,800 $90.74 p/Share
2,257 Reduced 14.34%
13,477 Common Stock

Also insider at

FOLD
AMICUS THERAPEUTICS, INC. Healthcare
ER

Eiry Roberts

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on NBIX

Follow NEUROCRINE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX